Symbols

ABMD(Delisted)

Abiomed·NASDAQ

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About ABMD

Abiomed, Inc.

A leading provider of medical technology that provides circulatory support and oxygenation

Industry

Established Date

Listing Date

07/31/1987

Exchange

NASDAQ Stock Exchange

Full-time Employees

2,003

Fiscal Year Ends

03-31

Website

www.abiomed.com

Security Type

Common stock

Office address

22 Cherry Hill Drive, Danvers, Massachusetts

Business

Introduction

Abiomed, Inc., was incorporated in Delaware in 1981. Abiomed is an industry-leading supplier of mechanical circulatory support equipment that provides continuous care to patients with heart failure. The company develops, produces and sells patented products that allow the heart to rest, heal and recover by improving blood flow or performing the pumping function of the heart. The Company's products are primarily used in cardiac catheterization laboratories, before surgeons require hemodynamic support for cardiac surgery, and during or after angioplasty or cardiac surgery. The company believes that the best clinical outcome for patients with heart failure is cardiac healing, as this restores their quality of life. In addition, the company believes that cardiac healing is the most cost-effective solution in the healthcare system for caring for these patients.

Company Financials

EPS

ABMD has released its 2023 Q2 earnings. EPS was reported at 1.3, versus the expected 1.04, beating expectations. The chart below visualizes how ABMD has performed over recent quarters, highlighting trends in earnings surprises.